Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

BUY
$25.89 - $29.73 $2.27 Million - $2.61 Million
87,703 New
87,703 $2.43 Million
Q1 2022

May 26, 2022

SELL
$45.75 - $56.69 $13.4 Million - $16.6 Million
-292,924 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$41.32 - $61.25 $12.1 Million - $17.9 Million
292,924 New
292,924 $17.3 Million
Q4 2019

Feb 07, 2020

SELL
$32.92 - $37.36 $4.12 Million - $4.68 Million
-125,264 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$32.49 - $42.13 $5.92 Million - $7.68 Million
-182,317 Reduced 59.27%
125,264 $4.5 Million
Q2 2019

Jul 30, 2019

SELL
$36.98 - $41.52 $1.84 Million - $2.07 Million
-49,848 Reduced 13.95%
307,581 $13.3 Million
Q1 2019

Apr 24, 2019

SELL
$37.5 - $41.2 $172 Million - $189 Million
-4,577,114 Reduced 92.76%
357,429 $15.2 Million
Q4 2018

Feb 08, 2019

BUY
$38.47 - $43.86 $4.27 Million - $4.87 Million
110,992 Added 2.3%
4,934,543 $215 Million
Q3 2018

Nov 13, 2018

BUY
$34.47 - $41.81 $14 Million - $17 Million
407,021 Added 9.22%
4,823,551 $213 Million
Q2 2018

Aug 10, 2018

BUY
$32.98 - $35.16 $4.17 Million - $4.45 Million
126,580 Added 2.95%
4,416,530 $160 Million
Q1 2018

May 14, 2018

SELL
$31.91 - $37.02 $25.7 Million - $29.8 Million
-804,617 Reduced 15.79%
4,289,950 $152 Million
Q4 2017

Feb 13, 2018

SELL
$33.26 - $35.29 $2.31 Million - $2.45 Million
-69,426 Reduced 1.34%
5,094,567 $185 Million
Q3 2017

Nov 13, 2017

BUY
$31.0 - $34.15 $160 Million - $176 Million
5,163,993
5,163,993 $184 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $139B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Ninety One Uk LTD Portfolio

Follow Ninety One Uk LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ninety One Uk LTD, based on Form 13F filings with the SEC.

News

Stay updated on Ninety One Uk LTD with notifications on news.